Table 1.
Cancer Type | CircRNA Symbol /CircBase ID |
Oncogenic /Tumor-Suppressive |
MicroRNA | Target Gene | Cancer Related Biological/Regulatory Process | Ref. |
---|---|---|---|---|---|---|
Lung cancer |
Circ_0000284 | oncogenic | miR-377-3p | PD-L1 | - | [47] |
Circ_0000376 | oncogenic | miR-1182 | NOVA2 | glycolysis, viability, migration, and invasion | [93] | |
Circ_0000677 | oncogenic | miR-106b-5p | CCND1 | proliferation | [94] | |
Circ_0020123 | oncogenic | miR-144 | ZEB1, EZH2 | growth and metastasis | [95] | |
Circ_0087862 | oncogenic | miR-1253 | RAB3D | tumor growth | [96] | |
Circ_BANP | oncogenic | miR-503 | LARP1 | cancer growth, migration and invasion | [97] | |
Circ_MAN2B2 | oncogenic | miR-1275 | FOXK1 | cell proliferation and invasion | [98] | |
Circ_PIP5K1A | oncogenic | miR-600 | HIF -1 α | proliferation and metastasis | [99] | |
Circ_PVT1 | oncogenic | miR-125b | E2F2 | Proliferation and Invasion | [100] | |
Circ_CDR1 | oncogenic | miR-641 | HOXA9 | cell stemness | [101] | |
Circ_103809 | oncogenic | miR-4302 | MYC | cell proliferation and invasion | [63] | |
ZNF121 | ||||||
Circ_HIPK3 | oncogenic | miR-124 | SphK1, STAT3, CDK4 | cell survival, proliferation, cell death and apoptosis | [64] | |
miR-149 | FOXM1 | cell proliferation and apoptosis | [65] | |||
Circ_PVT1 | oncogenic | miR-497 | Bcl-2 | aggressive clinicopathological characteristics and poor prognosis | [66] | |
Circ_ZNF208 | oncogenic | miR-7-5p | SNCA | radio-sensitivity of patients to X-rays | [67] | |
Circ_0046264 | Tumor-suppressive | miR-1245 | BRCA2 | apoptosis, proliferation and invasion | [102] | |
Circ_100395 | Tumor-suppressive | miR-1228 | TCF21 | proliferation, migration and invasion | [103] | |
Circ_cESRP1 | Tumor-suppressive | miR-93-5p | CDKN1A | sensitivity to chemotherapy | [68] | |
Circ_FOXO3 | Tumor-suppressive | miR-155 | FOXO3 | cell proliferation, migration and invasion | [104] | |
Colon cancer |
Circ_ERBIN | oncogenic | miR-125a-5p, miR-138-5p |
4EBP-1 | growth and metastasis | [105] |
Circ_0000467 | oncogenic | miR-4766-5p | KLF12 | proliferation, metastasis, and angiogenesis | [106] | |
Circ_0001313 | oncogenic | miR-510-5p | AKT2 | proliferation and apoptosis | [71] | |
Circ_0001946 | oncogenic | miR-135a-5p | - | proliferation and metastasis | [107] | |
Circ_0001982 | oncogenic | miR-144 | - | metastasis and poor prognosis | [69] | |
Circ_0004277 | oncogenic | miR-512-5p | PTMA | cell apoptosis and cell proliferation | [108] | |
Circ_0005963 | oncogenic | miR-122 | PKM2 | chemoresistance | [109] | |
Circ_0007843 | oncogenic | mIR-518c-5p | MMP2 | migration and invasion | [110] | |
Circ_000984 | oncogenic | miR-106b | CDK6 | cancer growth and metastasis | [75] | |
Circ_0053277 | oncogenic | miR-2467-3p | MMP14 | cell proliferation, migration, and EMT | [111] | |
Circ_0055625 | oncogenic | miR-106b-5p | ITGB8 | cell growth | [72] | |
Circ_0060745 | oncogenic | miR-4736 | CSE1L | proliferation and metastasis | [112] | |
Circ_CTNNA1 | oncogenic | miR-149-5p | FOXM1 | proliferation and invasion | [113] | |
Circ_HIPK3 | oncogenic | miR-7 | c-Myb | cancer growth and metastasis | [114] | |
Circ_HUWE1 | oncogenic | miR-486 | - | cell proliferation, migration and invasion | [70] | |
Circ_NSD2 | oncogenic | miR-199b-5p | DDR1, JAG1 | migration and metastasis | [76] | |
Circ_PRMT5 | oncogenic | miR-377 | E2F3 | proliferation | [115] | |
Circ_PTK2 | oncogenic | miR-136-5p | YTHDF1 | proliferation, migration, invasion and chemoresistance | [116] | |
Circ_UBAP2 | oncogenic | miR-199a | VEGFA | cell proliferation, migration, and invasion | [77] | |
Circ_ACAP2 | Tumor-suppressive | miR-21-5p | Tiam1 | proliferation, migration, and invasion | [117] | |
Liver cancer |
Circ_0003141 | oncogenic | miR-1827 | UBAP2 | proliferation and invasion | [118] |
Circ_0056836 | oncogenic | miR-766-3p | FOSL2 | cell migration, proliferation and invasion | [119] | |
Circ_0061395 | oncogenic | miR-877-5p | PIK3R3 | proliferation, invasion, and migration | [120] | |
Circ_FBLIM1 | oncogenic | miR-346 | FBLIM1 | cell proliferation, apoptosis and invasion | [121] | |
Circ_MAST1 | oncogenic | miR-1299 | CTNND1 | cell proliferation and migration | [122] | |
Circ_MET | oncogenic | miR-30-5p | Snail, DPP4, CXCL10 | epithelial to mesenchymal transition | [78] | |
Circ_ZNF566 | oncogenic | miR-4738-3p | TDO2 | cell migration, invasion, and proliferation | [123] | |
circ_0000673 | oncogenic | miR-767-3p | SET | cell proliferation and invasion | [124] | |
Circ_0001955 | oncogenic | miR-516a-5p | TRAF6, MAPK11 | tumor growth | [79] | |
Circ_0016788 | oncogenic | miR-486 | CDK4 | proliferation, invasion and apoptosis | [125] | |
Circ_0067934 | oncogenic | miR-1324 | FZD5 | proliferation, migration and invasion | [126] | |
Circ_103809 | oncogenic | miR-377-3p | FGFR1 | proliferation, cycle progression and migration | [127] | |
Circ_104348 | oncogenic | miR-187-3p | RTKN2 | proliferation, migration, invasion and apoptosis | [128] | |
Circ_Cdr1as | oncogenic | miR-7 | CCNE1, PIK3CD | proliferation and invasion | [129] | |
Circ_GFRA1 | oncogenic | miR-498 | NAP1L3 | growth and invasion | [130] | |
Circ_HIPK3 | oncogenic | miR-124 | AQP3 | cell proliferation and migration | [131] | |
Circ_MAT2B | oncogenic | miR-338-3p | PKM2 | glycolysis | [132] | |
Circ_5692 | Tumor-suppressive | miR-328-5p | DAB2IP | tumor growth | [80] | |
Circ_C3P1 | Tumor-suppressive | miR-4641 | PCK1 | tumor growth and metastasis | [81] | |
Circ_HIAT1 | Tumor-suppressive | miR-3171 | PTEN | cell growth | [82] | |
Gastric cancer |
ciRS-133 | oncogenic | miR-133 | PRDM16 | white adipose browning | [133] |
Circ_0006282 | oncogenic | miR-155 | FBXO22 | cell growth, proliferation and metastasis | [134] | |
Circ_0008035 | oncogenic | miR-375 | YBX1 | proliferation and invasion | [135] | |
Circ_0002360 | oncogenic | miR-629-3p | PDLIM4 | proliferation, invasion and oxidative stress | [85] | |
Circ_AKT3 | oncogenic | miR-198 | PIK3R1 | DNA damage repair and apoptosis | [136] | |
Circ_CACTIN | oncogenic | miR-331-3p | TGFBR1 | tumor growth and EMT | [137] | |
Circ_DLG1 | oncogenic | miR-141-3p | CXCL12 | proliferation, migration, invasion and immune evasion | [138] | |
Circ_MTO1 | oncogenic | miR-199a-3p | PAWR | tumor growth, apoptosis, invasion and migration | [139] | |
Circ_NHSL1 | oncogenic | miR-1306-3p | SIX1, vimentin | cell mobility, invasion and metastasis. | [86] | |
Circ_NRIP1 | oncogenic | miR-149-5p | AKT1 | proliferation, migration and invasion | [140] | |
Circ_PDSS1 | oncogenic | miR-186-5p | NEK2 | cell cycle and apoptosis | [141] | |
Circ_PVRL3 | oncogenic | miR-203, miR-1272, miR-1283, miR-31, miR-638, miR-496, miR-485-3p, miR-766, and miR-876-3p | - | proliferation and migration | [84] | |
Circ_0000039 | oncogenic | miR-1292-5p | DEK | proliferation, migration and invasion | [142] | |
Circ_RanGAP1 | oncogenic | miR-877–3p | VEGFA | invasion and metastasis | [143] | |
ciRS-7 | oncogenic | miR-7 | PTEN, PI3K | poor survival rate | [144] | |
Circ_0026344 | Tumor-suppressive | miR-590-5p | PDCD4 | cell proliferation, migration and invasion | [145] | |
Circ_CCDC9 | Tumor-suppressive | miR-6792-3p | CAV1 | tumor size, lymph node invasion, advanced clinical stage and survival rate | [87] | |
Circ_LARP4 | Tumor-suppressive | miR-424-5p | LATS1 | cell proliferation and invasion | [146] | |
Circ_MCTP2 | Tumor-suppressive | miR-99a-5p | MTMR3 | proliferation while promoting apoptosis of CDDP-resistant GC cells | [147] | |
Circ_PSMC3 | Tumor-suppressive | miR-296-5p | - | the proliferation and metastasis | [148] | |
Breast cancer |
Circ_0001982 | oncogenic | miR-1287-5p | MUC19 | glycolysis, proliferation, migration, and invasion | [149] |
Circ_0001429 | oncogenic | miR-205 | KDM4A | metastasis | [150] | |
Circ_0005230 | oncogenic | miR-618 | CBX8 | prognostic predictor | [151] | |
Circ_0008039 | oncogenic | miR-515-5p | CBX4 | proliferation, migration and invasion | [89] | |
Circ_0008039 | oncogenic | miR-432-5p | E2F3 | proliferation, cell-cycle progression and migration | [90] | |
Circ_0136666 | oncogenic | miR-1299 | CDK6 | proliferation, migration and invasion | [152] | |
Circ_100219 | oncogenic | miR-485-3p | NTRK3 | proliferation and migration | [153] | |
Circ_ANKS1B | oncogenic | miR-148a-3p, miR-152-3p |
USF1 | metastasis | [154] | |
Circ_BCBM1 | oncogenic | miR-125a | BRD4 | breast cancer brain metastasis | [92] | |
Circ_CER | oncogenic | miR-136 | MMP13 | cell proliferation and migration | [155] | |
Circ_FOXK2 | oncogenic | miR-370 | IGF2BP3 | migration and invasion | [156] | |
Circ_MYO9B | oncogenic | miR-4316 | FOXP4 | cell proliferation and invasion | [157] | |
Circ_PLK1 | oncogenic | miR-4500 | IGF1 | cell proliferation, migration and invasion | [158] | |
Circ_RHOT1 | oncogenic | miR-106a-5p | STAT3 | malignant progression and ferroptosis | [159] | |
Circ_RNF20 | oncogenic | miR-487a | HIF-1 α | proliferation, Warburg effect | [91] | |
Circ_RPPH1 | oncogenic | miR-556-5p | YAP1 | proliferation, migration, invasion, and angiogenesis | [160] | |
Circ_HIPK3 | oncogenic | miR-193a | HMGB1, PI3K, AKT | cell proliferation and invasion | [161] | |
Circ_0000442 | Tumor-suppressive | miR-148b-3p | PTEN | tumor growth | [162] | |
Circ_CCDC85A | Tumor-suppressive | miR-550a-5p | MOB1A | proliferation, migration and invasion | [163] |